+617.4%
MRNA vs RVMD
+620.8%
-3.5%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | RVMD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -2.1% | +2.8% | +1.2% |
| 7D | -8.2% | -3.6% | -4.7% | -7.6% |
| 30D | +125.6% | -1.1% | +126.6% | +125.8% |
| 3M | +197.1% | +41.0% | +156.0% | +177.6% |
| 6M | +148.5% | +105.7% | +42.8% | +111.6% |
| YTD | +363.3% | +155.3% | +208.0% | +272.5% |
| 1Y | +462.0% | +402.7% | +59.3% | +291.6% |
| 3Y | +26.9% | +533.1% | -506.2% | -18.8% |
| 5Y | -69.6% | +583.5% | -653.1% | -82.4% |
| All | +617.4% | +620.8% | -3.5% | +392.6% |
Cumulative growth
Daily Returns
Daily percentage return beside RVMD.
Daily Out/Under-Performance
Portfolio return minus RVMD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RVMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded RVMD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling